Public health authorities said that 4,740 adverse reactions had been reported among those who received the vaccines by Monday morning.
Meanwhile, a total of 5,769 doses have been wasted in the rollout, according to the Polish health ministry.
As of Monday, Poland had injected more than 2.9 million first doses, while over 1.6 million people have received a second shot, health ministry data showed.
Poland on Monday reported 10,896 new coronavirus infections and 28 more deaths, bringing its total number of cases during the pandemic to 1,917,527 and fatalities to 47,206.
New inoculation tactics
A new inoculation strategy came into force in Poland at the start of last week aiming to vaccinate as many people as quickly as possible with at least one anti-coronavirus shot amid a spike in infections.
The second dose of the AstraZeneca vaccine will now be administered 12 weeks after the first injection, while the Pfizer vaccine will be administered in two doses 42 days apart, according to Michał Dworczyk, the official spearheading the country’s inoculation drive.
In another measure brought in as Poland races to contain the virus, people who have been infected will receive a single shot no earlier than three months after they tested positive, announced Dworczyk, who is the Polish prime minister’s chief of staff.
Poland on Monday began administering COVID-19 vaccines to cancer patients and people suffering from various chronic health conditions.
Frontline healthcare workers were first in line to be inoculated in Poland, followed by nursing home residents.
Other priority groups for vaccination include the elderly, teachers, police, and soldiers.
Race to vaccinate
Health Minister Adam Niedzielski has said that the country hopes to vaccinate 60 to 70 percent of its population against the coronavirus by the autumn.
Prime Minister Mateusz Morawiecki announced in December that his government had secured vaccines for the Polish population from six leading international drug makers.
Dworczyk said last month that the country had ordered almost 100 million doses of COVID-19 vaccines in total, enough to inoculate 58 million people, more than its population of around 38 million.
Dworczyk said last Wednesday that Poland had secured assurances from vaccine manufacturers that around 15 million COVID-19 vaccine doses would be delivered to the country in the second quarter of this year.
This will include 2.5 million single-dose Johnson & Johnson shots, he told a news conference.
Michał Dworczyk, the man in charge of Poland's COVID-19 vaccination campaign. Photo: PAP/Radek Pietruszka
The European Union, of which Poland is part, has struck deals to secure vaccines from Pfizer-BioNTech, AstraZeneca, Moderna, CureVac, Sanofi-GSK, and Johnson & Johnson.
Niedzielski said last month that around 6.7 million coronavirus vaccine doses were expected to reach Poland by the end of March, including 4.8 million from Pfizer-BioNTech, 1.15 million from AstraZeneca, and 744,000 from Moderna.
He told a news conference earlier this month that Poland had ordered 16 million doses of a COVID-19 vaccine developed by US drug maker Johnson & Johnson and that the first shipments were expected to arrive in April.
Polish Health Minister Adam Niedzielski. Photo: PAP/Marcin Gadomski
On Monday, a fresh supply of around 380,000 doses of the Pfizer-BioNTech COVID-19 vaccine arrived in Poland, Deputy Health Minister Waldemar Kraska told the media.
Earlier this month, a shipment of the AstraZeneca-Oxford University vaccine had been expected but failed to reach the country, officials said, amid delays in deliveries from producers.
The prime ministers of Poland, Spain, Denmark and Belgium and the president of Lithuania last month called for stepped-up deliveries of COVID-19 vaccines in the EU.
Poland's Morawiecki earlier called on the EU's executive to use its sway to ensure the timely delivery of COVID-19 vaccines.
"Europe is a powerful market that has been hard hit by COVID-19," Morawiecki said. "Every day we are all paying a huge price for displaying a weakness toward drug makers. We can't stand aside and watch the next waves of infections engulf us."
The Polish health minister told reporters this month that the EU's drug regulator had opened a fast-track “rolling review” procedure for a COVID-19 vaccine being developed by American producer Novavax.
Officials in Warsaw announced on March 3 that domestic biotechnology firm Mabion had struck a deal with the US manufacturer to produce the Novavax vaccine in Poland.
The European Union on March 11 approved Johnson & Johnson's single-dose COVID-19 vaccine after a speedy review, raising hopes for stepped-up inoculation across the bloc.
(gs)
Source: IAR, gov.pl